Zura Bio Ltd
ZURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855644
No open-market purchases or sales by Zura Bio Ltd insiders were filed in the last 90 days; 95 institutions reported holding it in 13F filings for Q2 2026, worth $428.9M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Zura Bio Ltd changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 25 | 34 | +9 |
| Shares | 4.91M | 5.86M | +947.4K (+19.3%) |
| Value | $48.5M | $58.1M | +$9.59M (+19.8%) |
New holders (12)
Institutions that held Zura Bio Ltd at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Shaolin Capital Management LLC | 449,502 | $4.46M | 0.11% |
| Bank of Montreal | 388,700 | $3.85M | 0.00% |
| Context Capital Management, LLC | 100,000 | $991.0K | 0.06% |
| Capstone Investment Advisors, LLC | 100,000 | $991.0K | 0.02% |
| Sculptor Capital LP | 54,405 | $539.0K | 0.00% |
| Cohanzick Management, LLC | 50,000 | $496.0K | 0.11% |
| Deutsche Bank AG | 46,756 | $463.0K | 0.00% |
| Karpus Management, Inc. | 37,449 | $371.0K | 0.01% |
| Old Mission Capital LLC | 24,366 | $241.0K | 0.01% |
| Royal Bank of Canada | 13,970 | $138.0K | 0.00% |
| Ancora Advisors, LLC | 5,000 | $50.0K | 0.00% |
| UBS Group AG | 2,620 | $26.0K | 0.00% |
Sold out (3)
Institutions that held Zura Bio Ltd at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Boussard & Gavaudan Investment Management LLP | 375,000 | $3.69M |
| UBS Oconnor LLC | 257,885 | $2.54M |
| Schonfeld Strategic Advisors LLC | 20,010 | $197.0K |